ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects

ClinicalTrials.gov ID: NCT00312494

Public ClinicalTrials.gov record NCT00312494. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 8:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Three-Week, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Efficacy and Safety of Add-On Oral Ziprasidone in Subjects With Acute Mania Treated With Lithium or Divalproex

Study identification

NCT ID
NCT00312494
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Industry
Enrollment
680 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Ziprasidone Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2006
Primary completion
Nov 30, 2008
Completion
Nov 30, 2008
Last update posted
Mar 28, 2021

2006 – 2008

United States locations

U.S. sites
66
U.S. states
25
U.S. cities
54
Facility City State ZIP Site status
Pfizer Investigational Site Dothan Alabama 36303
Pfizer Investigational Site Scottsdale Arizona 85251
Pfizer Investigational Site Little Rock Arkansas 72211
Pfizer Investigational Site Cerritos California 90703
Pfizer Investigational Site Costa Mesa California 92626
Pfizer Investigational Site Escondido California 92025
Pfizer Investigational Site Glendale California 91204
Pfizer Investigational Site Huntington Beach California 92647
Pfizer Investigational Site Los Angeles California 90057
Pfizer Investigational Site Los Angeles California 90061
Pfizer Investigational Site National City California 91950
Pfizer Investigational Site Oceanside California 92056
Pfizer Investigational Site San Diego California 92114
Pfizer Investigational Site San Diego California 92120
Pfizer Investigational Site San Diego California 92126
Pfizer Investigational Site Torrance California 90505
Pfizer Investigational Site Hartford Connecticut 06106
Pfizer Investigational Site New Britain Connecticut 06050
Pfizer Investigational Site DeLand Florida 32720
Pfizer Investigational Site Fort Lauderdale Florida 33301
Pfizer Investigational Site Fort Lauderdale Florida 33308
Pfizer Investigational Site Gainesville Florida 32607
Pfizer Investigational Site Hollywood Florida 33021
Pfizer Investigational Site Jacksonville Florida 32256-2006
Pfizer Investigational Site Lauderhill Florida 33119
Pfizer Investigational Site North Miami Florida 33161
Pfizer Investigational Site Atlanta Georgia 30308
Pfizer Investigational Site Honolulu Hawaii 96813
Pfizer Investigational Site Des Plaines Illinois 60016
Pfizer Investigational Site Hoffman Estates Illinois 60169
Pfizer Investigational Site Hoffman Estates Illinois 60194
Pfizer Investigational Site Schaumburg Illinois 60194
Pfizer Investigational Site Greenwood Indiana 46143
Pfizer Investigational Site Prairie Village Kansas 66206
Pfizer Investigational Site Glen Burnie Maryland 21061
Pfizer Investigational Site Flowood Mississippi 39232
Pfizer Investigational Site Kansas City Missouri 64133
Pfizer Investigational Site Saint Charles Missouri 63304
Pfizer Investigational Site St Louis Missouri 63044-2588
Pfizer Investigational Site St Louis Missouri 63118
Pfizer Investigational Site St Louis Missouri 63128
Pfizer Investigational Site Las Vegas Nevada 89102
Pfizer Investigational Site Las Vegas Nevada 89103
Pfizer Investigational Site Clementon New Jersey 08021
Pfizer Investigational Site Princeton New Jersey 08540
Pfizer Investigational Site Amityville New York 11701
Pfizer Investigational Site Buffalo New York 14215
Pfizer Investigational Site Cedarhurst New York 11516
Pfizer Investigational Site Elmsford New York 10523
Pfizer Investigational Site Raleigh North Carolina 27609
Pfizer Investigational Site Cincinnati Ohio 45219
Pfizer Investigational Site Cincinnati Ohio 45220
Pfizer Investigational Site Cincinnati Ohio 45267-0559
Pfizer Investigational Site Cleveland Ohio 44113
Pfizer Investigational Site Oklahoma City Oklahoma 73112
Pfizer Investigational Site Philadelphia Pennsylvania 19149
Pfizer Investigational Site Charleston South Carolina 29405
Pfizer Investigational Site Dallas Texas 75228
Pfizer Investigational Site Irving Texas 75062
Pfizer Investigational Site Plano Texas 75024
Pfizer Investigational Site San Antonio Texas 78229-3900
Pfizer Investigational Site San Antonio Texas 78259-3509
Pfizer Investigational Site Richmond Virginia 23229
Pfizer Investigational Site Richmond Virginia 23230
Pfizer Investigational Site Bellevue Washington 98004
Pfizer Investigational Site Kirkland Washington 98033

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00312494, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 28, 2021 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00312494 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →